Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stevens

Showing results (51-60 of 279) with videos related to

Pageof 28
Sort By:
Medical Mycology|July 9, 2010
Developing a vaccine against aspergillosisDavid A Stevens, Karl V Clemons, Min Liu
The Journal of Infectious Diseases|August 22, 2006
Interferon- gamma as an antifungalDavid A Stevens, Elmer Brummer, Karl V Clemons
Neuroreport|September 10, 2003
Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicityLaura Facci, David A Stevens, Stephen D Skaper
Microbes and Infection|March 31, 2004
Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatusJung-Hyun Choi, Elmer Brummer, David A Stevens
Advances in Experimental Medicine and Biology|November 22, 2015
Mycologic EndocrinologyKarl V Clemons, Jata Shankar, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Experimental animal models of coccidioidomycosisKarl V Clemons, Javier Capilla, David A Stevens
Infectious Disease Clinics of North America|May 20, 2003
CoccidioidomycosisTom M Chiller, John N Galgiani, David A Stevens
Future Microbiology|November 26, 2013
Microbiology and epidemiology of Halomonas speciesKwang Kyu Kim, Jung-Sook Lee, David A Stevens
Antimicrobial Agents and Chemotherapy|March 26, 2003
Efficacy of micafungin alone or in combination against systemic murine aspergillosisJavier Capilla Luque, Karl V Clemons, David A Stevens
Antimicrobial Agents and Chemotherapy|August 31, 2006
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofunginDavid A Stevens, Masayuki Ichinomiya, Yukako Koshi, et al.
Pageof 28

Showing results (51-60 of 279) with videos related to

Sort By:
Pageof 28
Medical Mycology|July 9, 2010
Developing a vaccine against aspergillosisDavid A Stevens, Karl V Clemons, Min Liu
The Journal of Infectious Diseases|August 22, 2006
Interferon- gamma as an antifungalDavid A Stevens, Elmer Brummer, Karl V Clemons
Neuroreport|September 10, 2003
Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicityLaura Facci, David A Stevens, Stephen D Skaper
Microbes and Infection|March 31, 2004
Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatusJung-Hyun Choi, Elmer Brummer, David A Stevens
Advances in Experimental Medicine and Biology|November 22, 2015
Mycologic EndocrinologyKarl V Clemons, Jata Shankar, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Experimental animal models of coccidioidomycosisKarl V Clemons, Javier Capilla, David A Stevens
Infectious Disease Clinics of North America|May 20, 2003
CoccidioidomycosisTom M Chiller, John N Galgiani, David A Stevens
Future Microbiology|November 26, 2013
Microbiology and epidemiology of Halomonas speciesKwang Kyu Kim, Jung-Sook Lee, David A Stevens
Antimicrobial Agents and Chemotherapy|March 26, 2003
Efficacy of micafungin alone or in combination against systemic murine aspergillosisJavier Capilla Luque, Karl V Clemons, David A Stevens
Antimicrobial Agents and Chemotherapy|August 31, 2006
Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofunginDavid A Stevens, Masayuki Ichinomiya, Yukako Koshi, et al.
Pageof 28